EMA Recommends Valneva’s Chikungunya Vaccine for Use in Europe

The European Medicines Agency (EMA) has recommended Valneva’s single-dose chikungunya vaccine, Ixchiq, as the first preventive shot against the disease in Europe. With no approved drugs for chikungunya, the vaccine’s approval could be crucial in combating its spread in the region, especially with the increasing risks associated with climate change and global travel.